Efficacy and safety of EGFR inhibitors and radiotherapy in locally advanced non-small cell lung cancer-Supplementary Material
收藏数据链接：
官方服务：
资源简介：
Supplementary table 1: Prisma 2020 checklist <strong>Supplementary Table 2.</strong> Summary of efficacy <strong>Supplementary Table 3.</strong> The incidence of grade ≥3 AEs in NSCLC treated with EGFR inhibitors combined with (chemo)radiotherapy
提供机构：
Taylor & Francis创建时间：
2022-08-10
